Detalhe da pesquisa
1.
Differential contributions of rare and common, coding and noncoding Ret mutations to multifactorial Hirschsprung disease liability.
Am J Hum Genet
; 87(1): 60-74, 2010 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-20598273
2.
The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study.
Eur Heart J
; 33(17): 2143-50, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22450429
3.
A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk.
Nature
; 434(7035): 857-63, 2005 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-15829955
4.
Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder.
Depress Anxiety
; 27(5): 417-25, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20455246
5.
Prospective-retrospective biomarker analysis for regulatory consideration: white paper from the industry pharmacogenomics working group.
Pharmacogenomics
; 12(7): 939-51, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21787188